Moneycontrol PRO
Upcoming Event:Attend Algo Convention Live, 2 Days & 12+ Speakers at best offer Rs.999/-, exclusive for Moneycontrol Pro subscribers. Register now!

Buy Healthcare Global Enterprises; target of Rs 310: Edelweiss

Edelweiss is bullish on Healthcare Global Enterprises has recommended buy rating on the stock with a target price of Rs 310 in its research report dated May 25, 2017.

June 09, 2017 / 07:58 AM IST
  • bselive
  • nselive
Todays L/H

Edelweiss' research report on Healthcare Global Enterprises

Healthcare Global (HCG) reported in-line Q4FY17 with revenue and EBITDA growing 18% and 20% YoY, respectively. Existing oncology centers posted 17% YoY growth in revenue, while the new centres continued strong ramp up thereby reducing their EBITDA loss to INR 9mn (INR 14mn loss in Q3FY17).


We expect debt and capex to peak at INR 2bn and INR 5.1bn, respectively, by FY18 to fund expansion plans. In our view, HCG is positioned for robust EBITDA growth owing to strong therapy tailwind and EBITDA margin levers. We maintain ’BUY’ with a target price of INR 310 (18x FY19E EV/EBITDA).

For all recommendations, click here


Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Download your money calendar for 2022-23 here and keep your dates with your moneybox, investments, taxes

first published: May 26, 2017 04:46 pm
ISO 27001 - BSI Assurance Mark